In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response

被引:54
作者
Lamba, NMK
Courtney, JM
Gaylor, JDS
Lowe, GDO
机构
[1] Univ Strathclyde, Bioengn Unit, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Glasgow Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland
关键词
cellulose; polyvinylchloride; polyacrylonitrile; heparin; complement activation; contact activation;
D O I
10.1016/S0142-9612(99)00145-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This paper reports the results of an investigation into the blood response of polymers in vitro, using non-anticoagulated and heparinised blood and plasma. The materials studied were regenerated cellulose, (Cuprophan), an acrylonitrile-allyl sulphonate copolymer (AN69S), and medical grade polyvinyl chloride plasticised with di-2-ethyl-hexyl-phthalate (PVC/DEHP). Blood-material or plasma-material contact was achieved using a parallel plate flow cell, and C3a generation and FXII-like activity measured. The results of the study with non-anticoagulated human blood show that PVC/DEHP is a high complement activator. C3a concentration in the blood was higher after contact with PVC/DEHP than after contact with regenerated cellulose. The introduction of heparin in the blood induced complex alterations in the blood response. C3a generation could be elevated, decreased, or remain the same, depending on the material. The FXII-like activity on the surface of the PVC/DEHP after contact with plasma was also higher than the other two polymers. The introduction of heparin could increase or decrease FXII-like activity, depending on material. The patterns of response obtained with non-anticoagulated blood in vitro for AN69S and Cuprophan bore a strong resemblance with patterns of response obtained in the clinic, whereas those obtained with heparinised blood in vitro did not. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 46 条
[11]  
Edens E, 1993, COMPLEMENT PROFILES, V1, P96
[12]  
Falkenhagen D, 1987, Nephrol Dial Transplant, V2, P537
[13]   F-XII [J].
FUHRER, G ;
GALLIMORE, MJ ;
HELLER, W ;
HOFFMEISTER, HE .
BLUT, 1990, 61 (05) :258-266
[14]  
GALLIMORE M J, 1987, Fibrinolysis, V1, P123, DOI 10.1016/0268-9499(87)90020-8
[15]   MECHANISMS OF ACTIVATION OF THE CLASSICAL PATHWAY OF COMPLEMENT BY HAGEMAN-FACTOR FRAGMENT [J].
GHEBREHIWET, B ;
RANDAZZO, BP ;
DUNN, JT ;
SILVERBERG, M ;
KAPLAN, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (05) :1450-1456
[16]  
GOLDMAN M, 1987, LIFE SUPPORT SYST, V5, P317
[18]  
GUMA M, 1994, ASAIO J, P57
[19]   Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis? [J].
Hoenich, NA ;
Woffindin, C ;
Stamp, S ;
Roberts, SJ ;
Turnbull, J .
BIOMATERIALS, 1997, 18 (19) :1299-1303
[20]  
HOJIMA Y, 1984, BLOOD, V63, P1453